SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 28th, 2017 • Endonovo Therapeutics, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledDecember 28th, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 21, 2017, by and between Endonovo Therapeutics, Inc., a Delaware corporation, with headquarters located at 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA 91367, (the “Company”), and EAGLE EQUITIES, LLC, a Nevada limited liability company, with its address at 91 Shelton Ave, Suite 107, New Haven, CT 06511 (the “Buyer”).
SECURITY AGREEMENTSecurity Agreement • December 28th, 2017 • Endonovo Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 28th, 2017 Company Industry JurisdictionThis SECURITY AGREEMENT (the “Agreement”), dated and effective as of the 21day of December, 2018, is made by Endonovo Therapeutics, Inc. (“Debtor”) having a notice address of 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA 91367 in favor of EAGLE EQUITIES, LLC, a Nevada limited liability company, with its address at 91 Shelton Ave, Suite 107, New Haven, CT 06511 (“Secured Party”).